Skip to main content
Home

Breadcrumb

  1. Home
  2. Science and Engineering

Science and Engineering

Content maturity assessment: A growth roadmap for Life Science marketers
6 October 2026

Why many B2B content strategies stop delivering results

Most B2B companies produce content consistently, but fewer step back and assess whether that content is actually helping the business grow.Over time, content libraries often become fragmented: outdated articles remain live, messaging changes between channels, and new content is created ...

logo
29 September 2026

Why omnichannel lead strategies matter in complex B2B markets

Many B2B companies operate across multiple marketing channels, yet prospects often experience those channels as disconnected.A prospect may discover a company through LinkedIn, attend a webinar weeks later, download a technical guide, and only engage with sales months after that. When t...

Bottom-of-funnel marketing optimisation in Life Sciences
18 August 2026

Why Life Sciences and Biotech companies lose pipeline momentum at the bottom of the funnel

Many Life Sciences and Biotech companies invest heavily in awareness, content, and lead generation, yet still struggle to convert opportunities consistently at the final stage - the so called 'bottom of the funnel'.In our experience, the issue is often not lead volume but friction at th...

many white figures with one red figure standing out
29 May 2026

Protecting your staff and your organisation from fake recruitment scams

A fake recruiter message is one of the cleanest social engineering tricks around -because it doesn’t look like a trick. Here’s a few simple checks and rules to shut these scams down. ...

Middle-of-funnel marketing optimisation in Life Sciences
21 July 2026

Why the middle of the funnel is where most Life Science and Biotech growth stalls

Many B2B organisations focus heavily on generating leads and closing deals, but the middle of the funnel is often where growth actually stalls.This stage is where prospects move from initial interest into active evaluation. In sectors such as Life Sciences, buying decisions are rarely i...

Yourgene Health Logo
19 May 2026

Yourgene Health launches Insight DPYD Assay

Enhanced pharmacogenetic workflow includes additional variants to support safer, personalised chemotherapy treatment for cancer patients. ...

 AlgoDynamix CEO Dr. Jeremy Sosabowski receiving the Fintech Company of the Year Award (runner-up) at the prestigious Genome Campus just outside Cambridge.
20 May 2026

Cambridge Fintech Stars Take Centre Stage at Cambridge Independent Science and Technology Awards

London and Cambridge (UK), May 2026: Two of Cambridge’s leading fintech innovators, AlgoDynamix and SyndicateRoom, received major recognition at the recent Cambridge Independent Science and Technology Awards, held at the prestigious Genome Campus at Hinxton Hall. ...

Man in a suit sitting looking thoughtful
25 May 2026

The problem with CV shortcuts: they end at the interview

You know the feeling when your CV looks sharp. Every keyword in the job description has been ticked. And within 48 hours an interview invitation arrives. You think - I’ve cracked this! ...

Alchemie Technology Accelerates Japan Entry with EIT Calling2Scale
28 November 2025

Alchemie Technology accelerates Japan entry with EIT Calling2Scale

Alchemie Technology was selected as one of only 12 European companies for the EIT Global Outreach: Calling2Scale Gunma, an initiative of the EIT in partnership with the Governor of Gunma. ...

Cambridge science park image
18 May 2026

Cambridge Science Park submits masterplan to unlock the region's potential

Cambridge Science Park submits its masterplan for planning consent, continuing its commitment to a site that has been a cornerstone of the Cambridge phenomenon over the past 50 years. The plan is entirely privately funded, increasing built space from 2.8 million to approximately 8 milli...

Pagination

  • First page «
  • Previous page ‹‹
  • …
  • Page 15
  • Page 16
  • Current page 17
  • Page 18
  • Page 19
  • …
  • Next page ››
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS